# Relx plc: financial statements, quarterly

RELX · NYSE · CIK 929869 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/relx.md) · [Financials](/companies/relx/financials.md) · [Filings](/companies/relx/filings.md) · [Insiders](/companies/relx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/relx/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0001193125-18-053616.md) | [0.1](/filings/0001193125-19-055997.md) | [0.2](/filings/0001193125-20-042817.md) | [0.1](/filings/0001193125-21-047466.md) | [0.1](/filings/0001193125-22-045453.md) | [0.1](/filings/0001558370-23-001846.md) | [0.1](/filings/0001558370-24-001468.md) | [0.1](/filings/0001558370-25-001178.md) | [0.3](/filings/0001104659-26-017277.md) | [0.2](/filings/0001104659-26-017277.md) | [0.1](/filings/0001104659-26-017277.md) | [0.1](/filings/0001104659-26-017277.md) |
| Current assets | $bn | not reported | not reported | [2.4](/filings/0001193125-19-055997.md) | [2.2](/filings/0001193125-19-055997.md) | [2.4](/filings/0001193125-20-042817.md) | [2.4](/filings/0001193125-21-047466.md) | [2.3](/filings/0001193125-22-045453.md) | [2.4](/filings/0001558370-23-001846.md) | [3.1](/filings/0001558370-24-001468.md) | [2.9](/filings/0001558370-25-001178.md) | [3.0](/filings/0001104659-26-017277.md) | [3.0](/filings/0001104659-26-017277.md) |
| Total assets | $bn | not reported | not reported | [13.7](/filings/0001193125-19-055997.md) | [12.6](/filings/0001193125-19-055997.md) | [14.0](/filings/0001193125-20-042817.md) | [13.8](/filings/0001193125-21-047466.md) | [14.1](/filings/0001193125-22-045453.md) | [13.9](/filings/0001558370-23-001846.md) | [15.8](/filings/0001558370-24-001468.md) | [14.9](/filings/0001558370-25-001178.md) | [15.1](/filings/0001104659-26-017277.md) | [14.8](/filings/0001104659-26-017277.md) |
| Current liabilities | $bn | not reported | not reported | [5.3](/filings/0001193125-18-053616.md) | [4.5](/filings/0001193125-18-053616.md) | not reported | not reported | [4.4](/filings/0001193125-22-045453.md) | [3.7](/filings/0001558370-23-001846.md) | [5.2](/filings/0001558370-24-001468.md) | [5.5](/filings/0001558370-25-001178.md) | [5.7](/filings/0001104659-26-017277.md) | [6.0](/filings/0001104659-26-017277.md) |
| Total liabilities | $bn | not reported | not reported | [11.4](/filings/0001193125-19-055997.md) | [10.3](/filings/0001193125-19-055997.md) | [11.6](/filings/0001193125-20-042817.md) | [11.6](/filings/0001193125-21-047466.md) | [12.0](/filings/0001193125-22-045453.md) | [10.6](/filings/0001558370-23-001846.md) | [12.1](/filings/0001558370-24-001468.md) | [11.5](/filings/0001558370-25-001178.md) | [11.6](/filings/0001104659-26-017277.md) | [12.4](/filings/0001104659-26-017277.md) |
| Shareholders' equity | $bn | [2.1](/filings/0001193125-18-053616.md) | [2.2](/filings/0001193125-19-055997.md) | [2.3](/filings/0001193125-19-055997.md) | [2.3](/filings/0001193125-19-055997.md) | [2.3](/filings/0001193125-20-042817.md) | [2.2](/filings/0001193125-21-047466.md) | [2.1](/filings/0001193125-22-045453.md) | [3.2](/filings/0001558370-23-001846.md) | [3.8](/filings/0001558370-24-001468.md) | [3.5](/filings/0001558370-25-001178.md) | [3.5](/filings/0001104659-26-017277.md) | [2.4](/filings/0001104659-26-017277.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 1,819,061,446 at 2025-12-31, from the cover of the [20-F filed 2026-02-19](/filings/0001104659-26-017277.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.